BEAM logo

Beam Therapeutics Inc. (BEAM) EBIT

Annual EBIT:

-$415.57M-$239.08M(-135.47%)
December 31, 2024

Summary

  • As of today, BEAM annual earnings before interest & taxes is -$415.57 million, with the most recent change of -$239.08 million (-135.47%) on December 31, 2024.
  • During the last 3 years, BEAM annual EBIT has fallen by -$23.10 million (-5.89%).
  • BEAM annual EBIT is now -5173.71% below its all-time high of -$7.88 million, reached on December 31, 2017.

Performance

BEAM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

Quarterly EBIT:

-$120.15M-$865.00K(-0.73%)
June 30, 2025

Summary

  • As of today, BEAM quarterly earnings before interest & taxes is -$120.15 million, with the most recent change of -$865.00 thousand (-0.73%) on June 30, 2025.
  • Over the past year, BEAM quarterly EBIT has dropped by -$15.26 million (-14.54%).
  • BEAM quarterly EBIT is now -190.44% below its all-time high of $132.86 million, reached on December 31, 2023.

Performance

BEAM Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

TTM EBIT:

-$445.98M-$15.26M(-3.54%)
June 30, 2025

Summary

  • As of today, BEAM TTM earnings before interest & taxes is -$445.98 million, with the most recent change of -$15.26 million (-3.54%) on June 30, 2025.
  • Over the past year, BEAM TTM EBIT has dropped by -$261.54 million (-141.81%).
  • BEAM TTM EBIT is now -518.95% below its all-time high of -$72.05 million, reached on September 30, 2018.

Performance

BEAM TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

BEAM EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-135.5%-14.5%-141.8%
3Y3 Years-5.9%-46.6%-53.1%
5Y5 Years-453.0%-357.1%-276.9%

BEAM EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-135.5%at low-190.4%at low-152.7%at low
5Y5-Year-453.0%at low-190.4%+40.0%-276.9%at low
All-TimeAll-Time-5173.7%at low-190.4%+40.0%-519.0%at low

BEAM EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$120.15M(-0.7%)
-$445.98M(-3.5%)
Mar 2025
-
-$119.29M(-19.2%)
-$430.72M(-3.6%)
Dec 2024
-$415.57M(-135.5%)
-$100.04M(+6.1%)
-$415.57M(-127.5%)
Sep 2024
-
-$106.50M(-1.5%)
-$182.67M(+1.0%)
Jun 2024
-
-$104.89M(-0.7%)
-$184.44M(-1.5%)
Mar 2024
-
-$104.13M(-178.4%)
-$181.69M(-2.9%)
Dec 2023
-$176.49M(+47.9%)
$132.86M(+222.7%)
-$176.49M(+55.7%)
Sep 2023
-
-$108.27M(-6.0%)
-$398.33M(-4.4%)
Jun 2023
-
-$102.15M(-3.3%)
-$381.36M(-5.6%)
Mar 2023
-
-$98.93M(-11.2%)
-$361.18M(-6.7%)
Dec 2022
-$338.48M(+13.8%)
-$88.98M(+2.5%)
-$338.48M(-8.1%)
Sep 2022
-
-$91.30M(-11.4%)
-$312.98M(-7.4%)
Jun 2022
-
-$81.97M(-7.5%)
-$291.31M(-8.6%)
Mar 2022
-
-$76.22M(-20.1%)
-$268.32M(+31.6%)
DateAnnualQuarterlyTTM
Dec 2021
-$392.46M(-195.6%)
-$63.48M(+8.8%)
-$392.46M(-6.1%)
Sep 2021
-
-$69.63M(-18.1%)
-$369.78M(-9.6%)
Jun 2021
-
-$58.97M(+70.6%)
-$337.47M(-10.7%)
Mar 2021
-
-$200.37M(-391.1%)
-$304.78M(-129.6%)
Dec 2020
-$132.76M(-76.7%)
-$40.80M(-9.3%)
-$132.76M(-12.2%)
Sep 2020
-
-$37.32M(-42.0%)
-$118.33M(-19.5%)
Jun 2020
-
-$26.29M(+7.3%)
-$99.03M(-9.6%)
Mar 2020
-
-$28.36M(-7.5%)
-$90.40M(-20.3%)
Dec 2019
-$75.15M(-64.3%)
-$26.37M(-46.3%)
-$75.15M(-1.6%)
Sep 2019
-
-$18.02M(-2.1%)
-$73.98M(+42.2%)
Jun 2019
-
-$17.65M(-34.7%)
-$128.01M(-16.0%)
Mar 2019
-
-$13.11M(+48.0%)
-$110.36M(-13.5%)
Dec 2018
-$45.74M(-480.5%)
-$25.19M(+65.0%)
-$97.25M(-35.0%)
Sep 2018
-
-$72.05M
-$72.05M
Dec 2017
-$7.88M
-
-

FAQ

  • What is Beam Therapeutics Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. annual EBIT year-on-year change?
  • What is Beam Therapeutics Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. quarterly EBIT year-on-year change?
  • What is Beam Therapeutics Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. TTM EBIT year-on-year change?

What is Beam Therapeutics Inc. annual earnings before interest & taxes?

The current annual EBIT of BEAM is -$415.57M

What is the all-time high annual EBIT for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high annual earnings before interest & taxes is -$7.88M

What is Beam Therapeutics Inc. annual EBIT year-on-year change?

Over the past year, BEAM annual earnings before interest & taxes has changed by -$239.08M (-135.47%)

What is Beam Therapeutics Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of BEAM is -$120.15M

What is the all-time high quarterly EBIT for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high quarterly earnings before interest & taxes is $132.86M

What is Beam Therapeutics Inc. quarterly EBIT year-on-year change?

Over the past year, BEAM quarterly earnings before interest & taxes has changed by -$15.26M (-14.54%)

What is Beam Therapeutics Inc. TTM earnings before interest & taxes?

The current TTM EBIT of BEAM is -$445.98M

What is the all-time high TTM EBIT for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high TTM earnings before interest & taxes is -$72.05M

What is Beam Therapeutics Inc. TTM EBIT year-on-year change?

Over the past year, BEAM TTM earnings before interest & taxes has changed by -$261.54M (-141.81%)
On this page